CS Paper Radar

A Modular Agentic Framework for Synthetically Constrained Multi-Objective Hit-to-Lead Optimization

Kelvin P. Idanwekhai, Enes Kelestemur, Benjamin Strickland, Matthew Hart, Steini Davidsson, Angelos Angelopoulos, Ron Alterovitz, Marcello DeLuca, Alexander Tropsha

cs.AI cs.LGq-bio.QM ·submitted 2026-08-11 22:50 UTC · v1
code/data

Abstract

Hit-to-lead optimization requires iterative design of hit analogs across competing potency, selectivity, physicochemical, pharmacokinetic, safety, and synthetic constraints. We present SABLE (Synthetically-accessible Agentic Bayesian Ligand Exploration), an open-source framework that employs natural-language orchestration to guide chemical structure optimization. SABLE uses an LLM to interpret user-defined goals and route tasks, while specialized tools perform reaction-templated analog enumeration, physicochemical and ADMET property prediction, structure-based affinity scoring, and Bayesian optimization. The resulting workflow is a computational twin of the analytical and prioritization stages of the design-make-test-analyze cycle, providing provenance of each numerical output. Across single, and multi-objective optimization studies, SABLE enriches candidate sets for user-defined computational objectives while evaluating only a subset of the enumerated search space. Its modular architecture allows tools and characterization backends to be replaced by editing a simple config file, without modifying operational logic. SABLE provides an extensible decision-support framework for prioritizing synthetically constrained analogs in early-stage drug discovery.

Comment
22 pages, 9 figures

Closest papers

Nearest neighbours by meaning across the whole index.

From Benchmark to Bench: Can Agents Survive Real-World Drug Discovery?

cs.AI ·2026-10-05 ·Pierre Llompart, Levent Guner, Helen Lai, Alessandro Tibo, Yijie Xu
publishedbenchmark similarity 0.72
Abstract

Agentic systems increasingly coordinate molecular-design tools, but it is unclear which layer of the stack limits outcomes on real projects. We developed MAGI, an open modular agent that authors objectives, launches and monitors optimization, interprets structure--activity relationships, and revises its strategy accordingly. MAGI generates molecules either directly through the LLM or by delegating to REINVENT 4, with scoring services interchangeable behind a common contract. We tested it across nine retrospective lead-optimization campaigns from three pharmaceutical companies, replayed under fixed temporal cutoffs. Both routes produced valid structures: LLM proposals stayed closer to local chemistry and reached comparable or higher primary activity in fewer operations, whereas REINVENT explored broader chemical space. Whether a campaign met its objective depended on the predictive models, not on the generation route: attainment followed model accuracy on the chemistry proposed, dropping once that chemistry moved outside the model's applicability domain. Separately, a blinded evaluation asked whether the MAGI's output could pass as expert work: chemists were not able to discriminate agentic proposals from held-out compounds, and judged the SAR reasoning broadly plausible yet incomplete. Together, these results position MAGI as a coordination layer pluggable into existing computational chemistry workflows. The ceiling on real projects, however, remains currently set by scorer applicability rather than by tool orchestration.

0.26

M3OS: A Monte Carlo Graph Search-Orchestrated Multi-Agent LLM System for Evidence-Traced Molecular Optimization

cs.LG q-bio.BM ·2026-09-28 ·Junjie Wang, Yaowei Jin, Ruohui Tang, Guonan Cui, Haojie Wang +5 more
similarity 0.71
Abstract

Small-molecule optimization integrates medicinal-chemistry reasoning and computational evidence through iterative, multi-objective decisions. When large language models (LLMs) reason over optimization histories stored primarily in conversational context, they must recover candidate identities, prior evaluations, and task constraints to guide subsequent decisions. We present M3OS, a multi-agent LLM system that decouples molecular-design reasoning from optimization-state management through Monte Carlo graph search. A persistent graph links evaluated candidates, parent-child transformations and evaluation evidence, while rewards and visit statistics guide LLM-assisted parent selection. Two branches combine tool-driven candidate generation with knowledge- and case-guided medicinal-chemistry editing. An execution harness controls graph updates through structured output extraction, molecular validation and task-bound evaluation. Agents receive role-specific contexts, while the graph preserves optimization trajectories beyond their active contexts. Across three molecular optimization benchmarks, M3OS achieves higher success rates than baselines, supporting the integration of persistent search state, specialized agents and controlled execution for multi-constraint optimization.

0.21

TMCS: Tool-Grounded Multi-Agent Reasoning for Compositional Chemical Problem Solving

cs.AI cs.CV ·2026-09-28 ·Shengqin Wang, Jie Jin, Yu Cheng, Yihang Chen, Weilin Luo +2 more
similarity 0.71
Abstract

Despite the promise of Large Language Models (LLMs) in computational chemistry, rigorous combinatorial chemistry problems remain difficult because they require quantitatively constrained molecular modification, candidate validation, and systematic revision after failed attempts. Existing tool-augmented chemical agents demonstrate useful planning and tool use, but they rarely provide a unified loop for property-driven molecular optimization and workflow-level composition. To bridge this gap, we propose Tool-Grounded Multi-Agent Reasoning for Compositional Chemical Problem Solving (TMCS), a step-by-step multi-agent framework that formalizes chemical problem solving as an interpretable, tool-augmented workflow. At the task level, specialized agents leverage external tools, few-shot trajectory memory, and structured reflection to iteratively refine solutions. At the workflow level, TMCS chains generation, understanding, editing, description, and optimization into a closed-loop pipeline. Evaluations across multiple chemical tasks demonstrate that TMCS consistently enhances chemical reasoning across both open- and closed-source base models, achieving state-of-the-art performance.

0.12

ReMedI: Inference-Time Refinement and Self-Distillation for Controllable Molecular Optimization

cs.LG cs.AI ·2026-10-23 ·Jia Yi Zhang, Shivanshu Shekhar, Allison McLevige, Tong Zhang
position similarity 0.68
Abstract

In drug development, lead optimization must improve competing properties, such as increasing permeability and reducing toxicity, while limiting scaffold changes that could compromise the lead's potency. RL-based post-training, such as C-MORAL, addresses this problem by fine-tuning molecular language models to directly optimize molecular leads for objectives of interest, which relies on expensive task-specific datasets and faces challenges in achieving multi-objective optimization (MOO). We argue a pre-trained model may already contain useful molecular edits that zero-shot generation cannot efficiently reach. Motivated by the limited search capabilities of zero-shot generation, we develop an efficient Metropolis-Hastings search strategy to better explore the proposal distribution. We propose ReMedI, which uses the molecular language model as a base proposer for inference-time alignment. Given a lead and a set of multi-objective tasks, the model proposes edits conditioned on the current molecule, while Metropolis--Hastings refinement guides sequential edits under an objective for property improvement, preservation, and lead similarity. On both C-MuMOInstruct and SMDD benchmarks, refinement improves frozen base models across three backbones, reaching significantly higher multi-objective optimization success rates compared to baselines. These search traces can then distilled into the base model which improves zero-shot generation and subsequent search using approximately 7.8 times less training molecular leads than that of C-MORAL. ReMedI achieves approximately 2.8 times the strict-success coverage of RL baseline C-MORAL, including on out-of-distribution tasks, with matched lead-relative similarity.

0.05

PMO-Dock: Benchmarking Docking, Specificity, and Generalization in Molecular Optimization

cs.LG q-bio.QM ·2026-10-13 ·Gor Simonyan, Tatevik Abrahamyan, Narek Abelyan, Tigran Fahradyan, Hrant Khachatrian
benchmark similarity 0.68
Abstract

The Practical Molecular Optimization (PMO) benchmark standardized evaluation in molecular optimization, but it is built on simple property-based oracles that do not capture structure-based drug design. As the field has moved to docking-based objectives, evaluation practice has become unstandardized, and different methods report results on different docking tasks, often without a shared protocol for fair comparison or sample-efficiency constraints. To address this, we introduce Practical Molecular Optimization for Docking (PMO-Dock), a benchmark and protocol for docking-based optimization consisting of 25 tasks covering hit generation, lead optimization, and a new specificity task requiring strong on-target binding while penalizing off-target interactions. The protocol separates model development from final evaluation: validation tasks are used for hyperparameter tuning, and test tasks are held out for final evaluation and are not used during development. Evaluation on the test tasks is done under a strict oracle budget to reflect realistic drug-discovery settings. We benchmark four diverse high-performing methods spanning different optimization paradigms, Saturn (reinforcement learning), GenMol (discrete diffusion), Genetic-guided GFlowNet, and ChemLlama (LLM-based evolutionary search). Our results show no universally best method across tasks, additional analyses of hyperparameter transfer (cross-task and cross-category) and sensitivity show that transfer is often limited and varies by method, motivating method-dependent selection strategies. This benchmark provides a concrete standard for evaluating generalization to unseen tasks and sample efficiency under a limited test-time oracle budget.

0.18

SpecOpt: Contact-Diff Reasoning for Agentic Molecule Optimization Toward Binding Specificity

cs.AI ·2026-09-18 ·Thao Nguyen, Heng Ji
benchmark similarity 0.68
Abstract

Off-target protein binding is a major source of adverse effects for small-molecule drugs, yet most structure-based molecular design methods focus on generating selective compounds de novo rather than improving the selectivity of existing, well- characterized drugs. We introduce specificity optimization (SpecOpt), a molecular design task that seeks constrained structural modifications to an existing compound that increase its binding preference for an intended target over known off-targets while preserving its structural identity and drug-like properties. To enable systematic evaluation, we construct a ChEMBL-derived benchmark from compound-target interaction data, identifying intended targets through curated drug-mechanism annotations and off- targets through measured activities. We then develop an agentic framework that docks each compound against its intended target and off-targets, compares the resulting poses through residue-aware atom-protein contacts, and provides these differential interactions to a large language model to propose targeted structural modifications. Candidates are retained only if they satisfy molecular similarity, ADMET, and target-off-target docking selectivity criteria. On 915 compounds, the agent improves the target- off-target binding gap for 84.8% of compounds, shifting the mean gap from -0.72 to +0.47 kcal/mol while maintaining a mean Tanimoto similarity of 0.72 to the starting compounds. Ablation studies identify residue-specific contact information as the critical optimization signal: replacing residue identities with binary contact indicators eliminates improvement on all 29 ablation compounds. These results establish SpecOpt as a distinct molecular design problem and demonstrate residue-aware differential interactions as an effective signal for improving the specificity of existing compounds.

0.08

Closed-Loop Molecular Inverse Design with Semantic LLM Surrogates

cs.CL ·2026-08-24 ·Yaoyao Xu, Xinjian Zhao, Xiaozhuang Song, Lei Bai, Tianshu Yu
similarity 0.67
Abstract · 24 pages

Practical molecular inverse design is rarely a one-shot generation problem; it often involves enriching a pool of molecules that match a desired property profile under a limited oracle budget. Bayesian optimization (BO) offers a natural framework for this setting, with standard Gaussian-process (GP) surrogates operating in continuous embedding spaces. We propose LoopMol, a closed-loop framework whose large language model (LLM) surrogate reasons directly over task instructions, SMILES-level optimization histories, and oracle feedback. At each iteration, the surrogate selects informative reference molecules under an exploration--exploitation principle, optionally with a concise guidance sentence. These outputs condition the next generation round and yield an inspectable optimization trace. Experiments on six drug and material tasks across three Llamole backbones show that the LLM-based variant improves over one-shot generation and is competitive with or stronger than GP-based BO. They also reveal a domain-dependent interface: reference-only conditioning performs better on binary drug tasks, while adding a concise guidance sentence generally benefits continuous material tasks.

0.34

TRACE: Adaptive Trust-Region Bayesian Optimization for Open-Ended Molecular Design

cs.LG ·2026-11-09 ·Madhav R. Muthyala, Mahsa Askari, Farshud Sorourifar, Evan Zhou, Joe Gauthier +1 more
similarity 0.67
Abstract

Optimizing molecules under small evaluation budgets requires deciding both where in chemical space to search and which candidate within that region to evaluate. We introduce Trust Region Adaptive Chemical Exploration (TRACE), a framework for open-ended molecular Bayesian optimization (BO), where candidates are generated on demand rather than selected from a fixed library. TRACE combines an objective-free graph-perturbation mechanism with a fixed, chemistry-aware Gaussian process (GP) surrogate using fragprints, a representation combining molecular fingerprints and fragment descriptors. Rather than learning the search geometry itself, TRACE makes the scale of chemical exploration explicit through a Tanimoto-similarity threshold controlling chemical extent and a cardinality budget controlling candidate-search breadth. A simple success/failure controller expands or contracts both quantities during optimization, while the GP and acquisition function select which admissible molecules to evaluate. Across six challenging molecular optimization benchmarks under matched 1,000-evaluation budgets, TRACE achieves the strongest overall sample efficiency as measured by the best molecule found as evaluations accumulate. Crossed ablations on two objectives further show that adaptive region control contributes beyond the proposal mechanism, while its benefit depends on the proposal distribution. We further apply TRACE to the stability of iron phthalocyanine (FePc), a non-precious molecular electrocatalyst whose degradation can involve loss of the Fe center. Using a first-principles density functional theory (DFT) workflow designed for accurate energy evaluation, TRACE increases the computed thermodynamic resistance to Fe dissolution from 0.42 to 2.59 eV over 80 designed evaluations.

0.12